Shahid Akram’s Post

Key challenges of medication delivery to Kazakhstan. Part II. Where to contract pharmacy transportation from? Popular options include India, China, and the European Union — each offering distinct advantages. Importing from India India is known as the “pharmacy of the world,” and with good reason. It is the leading producer of generic medications, and its pharmaceutical industry adheres to stringent international quality standards. Contracting from India means access to affordable, high-quality drugs that meet global regulatory requirements. The country has a well-established pharmaceutical export infrastructure, meaning it’s no stranger to large-scale international deliveries. However, the key challenge lies in the distance and the sometimes lengthy customs process, which can delay shipments unless handled by experienced operators. Importing from China China is another major player in pharmaceutical exports, especially for active pharmaceutical ingredients. China is an appealing option if you’re looking to source bulk medications at competitive prices. The country has strong logistics networks and deep experience in global supply chain management, making it a reliable shipment source. Importing from the European Union Regarding contracting pharmacy transportation from Europe, Germany and Czechia are reliable sources. Both countries have highly advanced pharmaceutical industries, known for their quality control standards and adherence to EU regulations. Additionally, both countries have well-established logistics networks, allowing for seamless transportation routes to Kazakhstan. Part I https://lnkd.in/eFWR_FGk

India’s pharma exports surge to $27.9 billion, API imports pose a challenge 🤝 💊 Despite an increase in India's pharmaceutical exports to 6.4% in FY24 from 5.8% in FY19, the industry still relies on imports for APIs. This dependency, especially for antibiotics, was highlighted in the Economic Survey 2023-2024. The survey, presented by Finance Minister Nirmala Sitharaman, indicated that India’s pharmaceutical sector has strengthened its global position. Valued at $50 billion, it is the third-largest market worldwide by volume. Known as the "pharmacy of the world", India offers around 60,000 generic brands across 60 therapeutic categories, contributing 20% to global generic drug exports. Eight of the top 20 global generic companies are based in India. The sector maintains high compliance standards with numerous US FDA, European GMP, and WHO-GMP-approved facilities. Revised manufacturing rules under Schedule-M were introduced in December 2023 to enhance quality control. Despite these advancements, India remains reliant on imported APIs. The government’s Production-Linked Incentive (PLI) schemes have reduced some dependency by bolstering domestic manufacturing of antibiotics like Penicillin G and Clavulanic Acid. The PLI scheme for medical devices is also narrowing the gap between imports and exports. The initiative aims to make quality generic medicines available at affordable prices through Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs). Over 12,500 PMBJKs have been established, benefiting the general population and the economically disadvantaged. The sector’s growth is driven by innovation, with expectations to reach $130 billion by 2030. The future relies on advancements in biopharmaceuticals, skill development, and a robust supply chain. #pharmamanufacturing #contractmnaufacturing #healthcare #bigpharma

Expedite decision on anti-dumping duty on substandard IPA import from China: Pharma Experts "The unchecked dumping of underpriced, substandard IPA from China threatens India's efforts towards Atmanirbhar Bharat. Local producers struggle to compete, risking our production capacities and self-reliance on essential pharmaceutical supplies," said Vikas Biyani, an expert in FDA regulatory compliance and manufacturing of injectables. #Chinaimports I #IPA I #DGTR_investigation I #IsopropylAlcohol I #anti_dumping_duty I #domesticproduction I #AtmanirbharBharat Read more: https://lnkd.in/gweVprJj

In January-July of this year, #Azerbaijan imported $305.4 million worth of #pharmaceutical products. According to Iqtisadiyyat.az, this is 15.6% less than last year. Pharmaceutical products accounted for 2.83% of total imports during the reporting period. During the same period of 2023, Azerbaijan imported pharmaceuticals worth $362 million. Azerbaijan intends to reduce its dependence on imported #medicines by increasing local production. Thus, in March of this year, the board of the Ministry of #Health approved a list of #medications that will be produced in Azerbaijan. Approximately 70 types of #drugs will be produced locally under the decision. Economist Khalid Karimli believes that Azerbaijan's decline in drug imports is not due to increased production, but to the fact that after a surge in demand during the coronavirus pandemic, demand has now declined. “As a result of the pandemic, the state tried to create pharmaceutical stocks, so imports rose between 2020 and 2022. Azerbaijan is no longer in the midst of a drug boom and rush, which is why imports are declining," Karimli told Sputnik Azerbaijan. Furthermore, the expert noted, Azerbaijan can't replace imports through local production, since the country still has a limited capacity to produce medicines. As of now, there is only discussion about investing in this production sector and corresponding enterprises are being formed, according to the expert. A complete replacement of #pharmaceuticalimports with local production, according to Karimli, is also unrealistic in the future; only partial replacement can be achieved. It is also important to note that establishing local production in no way ensures better quality or cheaper products. #CIS; #healthcare

With the complex developments of the Covid-19 pandemic worldwide and in Vietnam specifically, the research, production, importation, and distribution of Covid-19 vaccines have become topics of great interest for everyone. Beyond domestic companies, foreign companies are also interested in the process to import, transport and to distribute pharmaceuticals in Vietnam. #Distribute_Pharmaceuticals_in_Vietnam

With the complex developments of the Covid-19 pandemic worldwide and in Vietnam specifically, the research, production, importation, and distribution of Covid-19 vaccines have become topics of great interest for everyone. Beyond domestic companies, foreign companies are also interested in the process to import, transport and to distribute pharmaceuticals in Vietnam. #Distribute_Pharmaceuticals_in_Vietnam

With the complex developments of the Covid-19 pandemic worldwide and in Vietnam specifically, the research, production, importation, and distribution of Covid-19 vaccines have become topics of great interest for everyone. Beyond domestic companies, foreign companies are also interested in the process to import, transport and to distribute pharmaceuticals in Vietnam. #Distribute_Pharmaceuticals_in_Vietnam

With the complex developments of the Covid-19 pandemic worldwide and in Vietnam specifically, the research, production, importation, and distribution of Covid-19 vaccines have become topics of great interest for everyone. Beyond domestic companies, foreign companies are also interested in the process to import, transport and to distribute pharmaceuticals in Vietnam. #Distribute_Pharmaceuticals_in_Vietnam

With the complex developments of the Covid-19 pandemic worldwide and in Vietnam specifically, the research, production, importation, and distribution of Covid-19 vaccines have become topics of great interest for everyone. Beyond domestic companies, foreign companies are also interested in the process to import, transport and to distribute pharmaceuticals in Vietnam. #Distribute_Pharmaceuticals_in_Vietnam

With the complex developments of the Covid-19 pandemic worldwide and in Vietnam specifically, the research, production, importation, and distribution of Covid-19 vaccines have become topics of great interest for everyone. Beyond domestic companies, foreign companies are also interested in the process to import, transport and to distribute pharmaceuticals in Vietnam. #Distribute_Pharmaceuticals_in_Vietnam